DrugPatentWatch Database Preview
EPOGEN/PROCRIT Drug Profile
» See Plans and Pricing
Summary for Tradename: EPOGEN/PROCRIT
Patents: | 99 |
Applicants: | 1 |
BLAs: | 1 |
Suppliers: see list | 2 |
Recent Clinical Trials: | See clinical trials for EPOGEN/PROCRIT |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for EPOGEN/PROCRIT |
Recent Clinical Trials for EPOGEN/PROCRIT
Identify potential brand extensions & biosimilar entrants
Sponsor | Phase |
---|---|
Sandoz | Phase 3 |
Recent Litigation for EPOGEN/PROCRIT
Identify key patents and potential future biosimilar entrants
District Court Litigation
Case Name | Date |
---|---|
Ameranth, Inc. v. Starbucks Corporation | 2013-05-06 |
Pharmacology for EPOGEN/PROCRIT
Ingredient-type | Erythropoietin |
Physiological Effect | Increased Erythroid Cell Production |
Company Disclosures: US Patents for EPOGEN/PROCRIT
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Amgen | EPOGEN/PROCRIT | epoetin alfa | VIAL; SINGLE-USE | 103234 | 001 | 1989-06-01 | Start Trial | Kirin-Amgen, Inc. (Thousand Oaks, CA) | 2012-08-15 | RX | company | |
Amgen | EPOGEN/PROCRIT | epoetin alfa | VIAL; SINGLE-USE | 103234 | 001 | 1989-06-01 | Start Trial | Kirin-Amgen, Inc. (Thousand Oaks, CA) | 2013-08-20 | RX | company | |
Amgen | EPOGEN/PROCRIT | epoetin alfa | VIAL; SINGLE-USE | 103234 | 001 | 1989-06-01 | Start Trial | Kirin-Amgen, Inc. (Thousand Oaks, CA) | 2003-12-13 | RX | company | |
Amgen | EPOGEN/PROCRIT | epoetin alfa | VIAL; SINGLE-USE | 103234 | 001 | 1989-06-01 | Start Trial | Amgen Inc. (Thousand Oaks, CA) | 2015-05-26 | RX | company | |
Amgen | EPOGEN/PROCRIT | epoetin alfa | VIAL; SINGLE-USE | 103234 | 001 | 1989-06-01 | Start Trial | Kirin-Amgen, Inc. (Thousand Oaks, CA) | 2016-09-21 | RX | company | |
Amgen | EPOGEN/PROCRIT | epoetin alfa | VIAL; MULTIDOSE | 103234 | 002 | 1989-06-01 | Start Trial | Kirin-Amgen, Inc. (Thousand Oaks, CA) | 2012-08-15 | RX | company | |
Amgen | EPOGEN/PROCRIT | epoetin alfa | VIAL; MULTIDOSE | 103234 | 002 | 1989-06-01 | Start Trial | Kirin-Amgen, Inc. (Thousand Oaks, CA) | 2013-08-20 | RX | company | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
Patent Text Search: US Patents for EPOGEN/PROCRIT
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Amgen | EPOGEN/PROCRIT | epoetin alfa | VIAL; SINGLE-USE | 103234 | 001 | 1989-06-01 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2033-03-11 | RX | search | |
Amgen | EPOGEN/PROCRIT | epoetin alfa | VIAL; SINGLE-USE | 103234 | 001 | 1989-06-01 | Start Trial | AMGEN INC. (Thousand Oaks, CA) | 2039-02-26 | RX | search | |
Amgen | EPOGEN/PROCRIT | epoetin alfa | VIAL; SINGLE-USE | 103234 | 001 | 1989-06-01 | Start Trial | 2036-04-01 | RX | search | ||
Amgen | EPOGEN/PROCRIT | epoetin alfa | VIAL; SINGLE-USE | 103234 | 001 | 1989-06-01 | Start Trial | MIDWESTERN UNIVERSITY (Downers Grove, IL) | 2027-08-21 | RX | search | |
Amgen | EPOGEN/PROCRIT | epoetin alfa | VIAL; SINGLE-USE | 103234 | 001 | 1989-06-01 | Start Trial | YALE UNIVERSITY (New Haven, CT) | 2039-02-26 | RX | search | |
Amgen | EPOGEN/PROCRIT | epoetin alfa | VIAL; SINGLE-USE | 103234 | 001 | 1989-06-01 | Start Trial | GENOSCIENCE PHARMA (Marseilles, FR) | 2039-02-26 | RX | search | |
Amgen | EPOGEN/PROCRIT | epoetin alfa | VIAL; SINGLE-USE | 103234 | 001 | 1989-06-01 | Start Trial | ChemoCentryx, Inc. (Mountain View, CA) | 2036-06-13 | RX | search | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for EPOGEN/PROCRIT
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 2018095554 | Start Trial |
Canada | 2861459 | Start Trial |
European Patent Office | 1833470 | Start Trial |
Japan | 6326124 | Start Trial |
Poland | 2182977 | Start Trial |
Australia | 2016200097 | Start Trial |
Taiwan | 201006496 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |